The DOI matches its Crossref record.
A New Theory on the Cancer-inducing Mechanism
Open accessAbstract
RECENT research in genetics and pathology has shown an amazing consistency between the agents causing mutations and those causing-or contributing to the development of-cancer. One of the more prominent theories, which since the 1920's has been advocated by Bauer (1949), Strong (1949) and others, claims that the original cancerous cell is nothing but an ordinary cell affected by genetic mutation of some kind. One of the main objections to this theory has been that it does not explain the age variation of the cancer frequency. In reply, Bauer (1949) contends that the mutated cells apparently remain latent during a long period until the new qualities become evident and the phenomenon can be diagnosed as cancer. Bauer has found this period of latency to average 9 years for X-ray cancer, 12 years for paraffin cancer, 18 years for aniline cancer and 40 years for seaman's cancer (caused by solar radiation). The early occurrence of sarcoma and of leukaemia, however, does not conform to the idea of a latent period. Moreover, it appears somewhat unreasonable to suppose that the length of the latency period would depend upon whether the mutation is caused by sun-rays or by X-rays. Writh most forms of carcinoma, furthermore, the frequency at different ages is such that wre are compelled to consider average latency periods of 70 years or more, in order to explain the actual age frequency curve of cancer mortality in man. These facts still make it difficult for many of the most competent authorities in the field to accept the mutation theory without reservations. Dahlberg (1943) has advanced a completely different explanation concerning the relationship between age and cancer. He expressed the opinion that malignant tumours develop increasingly easily with rising age. This implies that, for the development of tumourous cells, it is necessary for a certain number of cellular divisions to have taken place, between each of which there has been a certain period of time. All experience concerning the cancerous influence of chronic irritations promoting cellular divisions seems strongly to support this theory. The question then arises of the nature of the process taking place in the cells during the intervals between their various divisions. According to the theory advanced in 1934 by Timof6eff-Ressofsky, Delbruck and Zimmer (1935) and discussed by Schroedinger (1944), mutations constitute such a process, which goes on incessantly in every large group of cells. Mutations are caused, according to …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Universal Patterns of Selection in Cancer and Somatic Tissues
Martincorena, I., Raine, K. M., Gerstung, M., Dawson, K. J., Haase, K., Van Loo, P., Davies, H., Stratton, M. R., & Campbell, P. J. (2017) · Cell · doi:10.1016/j.cell.2017.09.042 · Cited by 1,523
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Venous thrombosis: a multicausal disease
Rosendaal, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10266-0 · Cited by 1,576
Epidemiology and the web of causation: has anyone seen the spider?
Krieger, N. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90202-x · Cited by 1,731
The age distribution of cancer and a multi-stage theory of carcinogenesis
Armitage, P., & Doll, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602297 · Cited by 1,285
Mutational signatures associated with tobacco smoking in human cancer
Alexandrov, L. B., Ju, Y. S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., et al. (2016) · Science · doi:10.1126/science.aag0299 · Cited by 1,100
Two genetic hits (more or less) to cancer
Knudson, A. G. (2001) · Nature Reviews Cancer · doi:10.1038/35101031 · Cited by 1,127
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Tomasetti, C., Li, L., & Vogelstein, B. (2017) · Science · doi:10.1126/science.aaf9011 · Cited by 1,113
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
Clonal evolution of glioblastoma under therapy
Wang, J., Cazzato, E., Ladewig, E., Frattini, V., Rosenbloom, D. I. S., Zairis, S., Abate, F., Liu, Z., Elliott, O., Shin, Y.-J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3590 · Cited by 720
The mathematics of cancer: integrating quantitative models
Altrock, P. M., Liu, L. L., & Michor, F. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4029 · Cited by 685
DNA Damage, Mutagenesis and Cancer
Basu, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040970 · Cited by 522
Two-event models for carcinogenesis: incidence curves for childhood and adult tumors
Moolgavkar, S. H., & Venzon, D. J. (1979) · Mathematical Biosciences · doi:10.1016/0025-5564(79)90005-1 · Cited by 513
The aging lung: Physiology, disease, and immunity
Schneider, J. L., Rowe, J. H., Garcia-de-Alba, C., Kim, C. F., Sharpe, A. H., & Haigis, M. C. (2021) · Cell · doi:10.1016/j.cell.2021.03.005 · Cited by 500
Dynamics of cancer progression
Michor, F., Iwasa, Y., & Nowak, M. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1295 · Cited by 483
How many mutations are required for tumorigenesis? implications from human cancer data
Balmain, A., Barrett, J. C., Moses, H., & Renan, M. J. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070303 · Cited by 464
Dissecting cancer through mathematics: From the cell to the animal model
Byrne, H. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2808 · Cited by 442
Evaluating intrinsic and non-intrinsic cancer risk factors
Wu, S., Zhu, W., Thompson, P., & Hannun, Y. A. (2018) · Nature Communications · doi:10.1038/s41467-018-05467-z · Cited by 437
Nanomaterial Applications in Photothermal Therapy for Cancer
Doughty, A. C. V., Hoover, A. R., Layton, E., Murray, C. K., Howard, E. W., & Chen, W. R. (2019) · Materials · doi:10.3390/ma12050779 · Cited by 436
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
Al-Chalabi, A., Calvo, A., Chio, A., Colville, S., Ellis, C. M., Hardiman, O., Heverin, M., Howard, R. S., Huisman, M. H. B., Keren, N., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70219-4 · Cited by 411
Genetic Progression and the Waiting Time to Cancer
Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., & Nowak, M. A. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030225 · Cited by 408
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Only three driver gene mutations are required for the development of lung and colorectal cancers
Tomasetti, C., Marchionni, L., Nowak, M. A., Parmigiani, G., & Vogelstein, B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421839112 · Cited by 395
Thymic involution and rising disease incidence with age
Palmer, S., Albergante, L., Blackburn, C. C., & Newman, T. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714478115 · Cited by 364
“Nordling CO (1953) A new theory on cancer-inducing mechanism.”
BackgroundMultistage carcinogenesis and the incidence of colorectal cancer
Luebeck, E. G., & Moolgavkar, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222118199 · Cited by 358
The landscape of the mesenchymal signature in brain tumours
Behnan, J., Finocchiaro, G., & Hanna, G. (2019) · Brain · doi:10.1093/brain/awz044 · Cited by 350
Cancer Evolution: Mathematical Models and Computational Inference
Beerenwinkel, N., Schwarz, R. F., Gerstung, M., & Markowetz, F. (2015) · Systematic Biology · doi:10.1093/sysbio/syu081 · Cited by 345
Mechanisms of cancer resistance in long-lived mammals
Seluanov, A., Gladyshev, V. N., Vijg, J., & Gorbunova, V. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0004-9 · Cited by 323
A mathematical model for the age distribution of cancer in man
Cook, P. J., Doll, R., & Fellingham, S. A. (1969) · International Journal of Cancer · doi:10.1002/ijc.2910040113 · Cited by 282
Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193
The Fluid Mechanics of Cancer and Its Therapy
Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129
Senescent cells and the incidence of age‐related diseases
Katzir, I., Adler, M., Karin, O., Mendelsohn‐Cohen, N., Mayo, A., & Alon, U. (2021) · Aging Cell · doi:10.1111/acel.13314 · Cited by 85
Metadata
- Authors
- Nordling, C. O.
- Venue
- British Journal of Cancer
- Published
- 1953-03
- Volume
- 7
- Issue
- 1
- Pages
- 68-72
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2045582876
- Cited by
- 776
- References
- 0
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.